Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT02596633
Other study ID # 14094
Secondary ID
Status Active, not recruiting
Phase Phase 3
First received October 16, 2015
Last updated February 17, 2016
Start date January 2015
Est. completion date April 2016

Study information

Verified date February 2016
Source University of Nottingham
Contact n/a
Is FDA regulated No
Health authority United Kingdom: Research Ethics Committee
Study type Interventional

Clinical Trial Summary

This study will investigate the feasibility of running a randomised controlled trial (RCT) of a psychotherapy called "Acceptance and Commitment Therapy (ACT)", delivered in a self-help format with additional telephone support from a therapist, for people with Multiple Sclerosis (MS) and low mood.


Description:

A large proportion of people with Multiple Sclerosis (MS) suffer from emotional problems, therefore a large percentage of people with MS would be eligible to take part in a study offering a psychotherapeutic component to address these issues.

Acceptance and Commitment Therapy (ACT) has been found to be effective for mood problems, and been successfully used in self-help format, but no study has thus-far examined potential for use as an effective intervention in this (MS) population.

People will MS and low mood will be recruited from a neurology outpatient clinic. They will be randomized to either receive treatment as usual, or an ACT self-help book with 8 supportive telephone calls from a trainee clinical psychologist. Measures of anxiety, depression, quality of life and physical health will be administered at baseline, post-intervention and six month follow up. A sub sample of 10 participants will be interviewed to find out their view on taking part in the study.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 30
Est. completion date April 2016
Est. primary completion date March 2016
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Diagnosis of MS. Over 7 on the Hospital Anxiety and Depression Scale

Exclusion Criteria:

- Already receiving psychotherapy

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Behavioral:
Telephone-support Acceptance and Commitment Therapy (ACT)
Telephone-support Acceptance and Commitment Therapy (ACT): ACT self-help book and 8 telephone support calls

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
University of Nottingham

Outcome

Type Measure Description Time frame Safety issue
Primary Feasibility of recruitment, measured with telephone-interviews. A sub-sample of participants will be interviewed over the phone to assess their views on their recruitment into the trial. At post-intervention, which is the specific time point when participants report to the researchers that they have finished their self-help books and support calls, or exactly 12 weeks after randomisation for those in the treatment-as-usual arm No
Primary Feasibility of randomisation, measured with telephone-interviews. A sub-sample of participants will be interviewed over the phone to assess their views on how they were randomised. At post-intervention, which is the specific time point when participants report to the researchers that they have finished their self-help books and support calls, or exactly 12 weeks after randomisation for those in the treatment-as-usual arm No
Primary Feasibility of psychometric assessment, measured with telephone-interviews. A sub-sample of participants will be interviewed over the phone to assess their views on the battery of psychometric assessments. At post-intervention, which is the specific time point when participants report to the researchers that they have finished their self-help books and support calls, or exactly 12 weeks after randomisation for those in the treatment-as-usual arm No
Primary Feasibility of the self-help book, measured with telephone-interviews. A sub-sample of participants will be interviewed over the phone to assess their views on the self-help book. At post-intervention, which is the specific time point when participants report to the researchers that they have finished their self-help books and support calls, or exactly 12 weeks after randomisation for those in the treatment-as-usual arm No
Primary Feasibility of the telephone-support calls, measured with telephone-interviews. A sub-sample of participants will be interviewed over the phone to assess their views on the telephone support calls. At post-intervention, which is the specific time point when participants report to the researchers that they have finished their self-help books and support calls, or exactly 12 weeks after randomisation for those in the treatment-as-usual arm No
Secondary Effectiveness in reducing anxiety, as measured using online psycho-metrics. Effectiveness will be assessed using quantitative measures which will be completed by participants online. At post-intervention (12 weeks after randomisation) and 6 months after randomisation No
Secondary Effectiveness in reducing depression, as measured using online psycho-metrics. Effectiveness will be assessed using quantitative measures which will be completed by participants online. At post-intervention (12 weeks after randomisation) and 6 months after randomisation No
Secondary Effectiveness in reducing physical health problems, as measured using online psycho-metrics. Effectiveness will be assessed using quantitative measures which will be completed by participants online. At post-intervention (12 weeks after randomisation) and 6 months after randomisation No
Secondary Effectiveness in increasing quality of life, as measured using online psycho-metrics. Effectiveness will be assessed using quantitative measures which will be completed by participants online. At post-intervention (12 weeks after randomisation) and 6 months after randomisation No
See also
  Status Clinical Trial Phase
Completed NCT05528666 - Risk Perception in Multiple Sclerosis
Completed NCT03608527 - Adaptive Plasticity Following Rehabilitation in Multiple Sclerosis N/A
Recruiting NCT05532943 - Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis Phase 1/Phase 2
Completed NCT02486640 - Evaluation of Potential Predictors of Adherence by Investigating a Representative Cohort of Multiple Sclerosis (MS) Patients in Germany Treated With Betaferon
Completed NCT01324232 - Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis Phase 2
Completed NCT04546698 - 5-HT7 Receptor Implication in Inflammatory Mechanisms in Multiple Sclerosis
Active, not recruiting NCT04380220 - Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple Sclerosis
Completed NCT02835677 - Integrating Caregiver Support Into MS Care N/A
Completed NCT03686826 - Feasibility and Reliability of Multimodal Evoked Potentials
Recruiting NCT05964829 - Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis N/A
Withdrawn NCT06021561 - Orofacial Pain in Multiple Sclerosis
Completed NCT03653585 - Cortical Lesions in Patients With Multiple Sclerosis
Recruiting NCT04798651 - Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis N/A
Active, not recruiting NCT05054140 - Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis Phase 2
Completed NCT05447143 - Effect of Home Exercise Program on Various Parameters in Patients With Multiple Sclerosis N/A
Recruiting NCT06195644 - Effect of Galvanic Vestibular Stimulation on Cortical Excitability and Hand Dexterity in Multiple Sclerosis Patients Phase 1
Completed NCT04147052 - iSLEEPms: An Internet-Delivered Intervention for Sleep Disturbance in Multiple Sclerosis N/A
Completed NCT03594357 - Cognitive Functions in Patients With Multiple Sclerosis
Completed NCT03591809 - Combined Exercise Training in Patients With Multiple Sclerosis N/A
Completed NCT02845635 - MS Mosaic: A Longitudinal Research Study on Multiple Sclerosis